Global Digital Biomarkers Market (2020 to 2030) - by System Component, Therapeutic Area, Application, Development Status, End-user and Region - ResearchAndMarkets.com

DUBLIN--()--The "Global Digital Biomarkers Market 2020-2030 by System Component, Therapeutic Area, Application, Development Status, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global digital biomarkers market will reach $22.54 billion by 2030, growing by 36.2% annually over 2020-2030 driven by rising demand for mobile health apps, elevated level of smartphone and wearable technology in healthcare.

The report is based on a comprehensive research of the entire global digital biomarkers market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter's Five Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital biomarkers market in every aspect of the classification from perspectives of System Component, Therapeutic Area, Application, Development Status, End User, and Region.

Key Players:

  • Actigraph LLC
  • Akili Interactive Labs
  • AliveCor Inc
  • Altoida Inc
  • Amgen Inc
  • Bayer AG
  • Biogen Inc
  • Cambridge Cognition Plc
  • Eli Lilly and Company
  • Evidation Health, Inc.
  • F. Hoffmann-La Roche Ltd
  • Fitbit Inc
  • GlaxoSmithKline Plc
  • Happify Health
  • Human API
  • IXICO Plc
  • Koninklijke Philips N.V.
  • Medical Care Corporation
  • Medopad Ltd
  • Mindstrong Health
  • Neurotrack Technology, Inc
  • Novartis International AG
  • Pfizer Inc.
  • Quanterix Corporation
  • Sanofi S.A.
  • The Takeda Pharmaceuticals Company Limited
  • Verily Life Sciences
  • Winterlight Labs Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's five Forces Analysis

3 Segmentation of Global Market by System Component

3.1 Market Overview by System Component

3.2 Data Collection Tools

3.2.1 Digital Platforms

3.2.2 Mobile Apps

3.2.3 Desktop-based Software

3.2.4 Wearables

3.2.5 Biosensors

3.3 Data Integration Systems

4 Segmentation of Global Market by Therapeutic Area

4.1 Market Overview by Therapeutic Area

4.2 Cardiovascular Diseases

4.3 Neurodegenerative Disorders

4.3.1 Parkinson's Disease

4.3.2 Multiple Sclerosis

4.3.3 Alzheimer's Disease

4.4 Sleep and Movement Diseases

4.5 Psychiatric Disorders

4.6 Chronic Pain

4.7 Gastrointestinal Diseases

4.8 Diabetes

4.9 Respiratory Conditions

4.10 Other Diseases

5 Segmentation of Global Market by Application

5.1 Market Overview by Application

5.2 Wellness

5.3 Disease Diagnosis

5.4 Personalised Medication

5.5 Drug Discovery and Development

6 Segmentation of Global Market by Development Status

6.1 Market Overview by Development Status

6.2 Novel Digital Biomarkers

6.3 Original Digital Biomarkers

6.4 Approved Digital Biomarkers

7 Segmentation of Global Market by End User

7.1 Market Overview by End User

7.2 Biopharmaceutical Companies & Labs

7.3 Healthcare Providers

7.4 Insurance Payers

8 Segmentation of Global Market by Region

8.1 Geographic Market Overview 2019-2030

8.2 North America Market 2019-2030 by Country

8.2.1 Overview of North America Market

8.2.2 U.S.

8.2.3 Canada

8.2.4 Mexico

8.3 European Market 2019-2030 by Country

8.3.1 Overview of European Market

8.3.2 Germany

8.3.3 UK

8.3.4 France

8.3.5 Netherlands

8.3.6 Italy

8.3.7 Russia

8.3.8 Rest of European Market

8.4 Asia-Pacific Market 2019-2030 by Country

8.4.1 Overview of Asia-Pacific Market

8.4.2 Japan

8.4.3 China

8.4.4 Australia

8.4.5 India

8.4.6 South Korea

8.4.7 Rest of APAC Region

8.5 South America Market 2019-2030 by Country

8.5.1 Argentina

8.5.2 Brazil

8.5.3 Chile

8.5.4 Rest of South America Market

8.6 MEA Market 2019-2030 by Country

8.6.1 UAE

8.6.2 Saudi Arabia

8.6.3 Israel

8.6.4 Other National Markets

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

10 Investing in Global Market: Risk Assessment and Management

10.1 Risk Evaluation of Global Market

10.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/u8op7y

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900